Treatment approaches for nasopharyngeal adenoid cystic carcinoma

References

• Chang ET, Adami H. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1765–1777.
   PubMed Web of Science ®Google Scholar
• He JH, Zong YS, Luo RZ, et al. Clinicopathological characteristics of primary nasopharyngeal adenocarcinoma. Ai Zheng. 2003;22:753–757.
   PubMedGoogle Scholar
• Yin ZY, Wu XL, Hu YH, et al. Cylindroma of the nasopharynx: a chronic disease. Int J Radiat Oncol Biol Phys. 1986;12:25–30.
   PubMed Web of Science ®Google Scholar
• Lee DJ, Smith RR, Spaziani JT, et al. Adenoid cystic carcinoma of the nasopharynx. Case reports and literature review. Ann Otol Rhinol Laryngol. 1985;94:269–272.
   PubMed Web of Science ®Google Scholar
• Wang C, See L, Hong J, et al. Nasopharyngeal adenoid cystic carcinoma: five new cases and a literature review. J Otolaryngol. 1996;25:399–403.
   PubMedGoogle Scholar
• Schramm VL, Imola MJ. Management of nasopharyngeal salivary gland malignancy. Laryngoscope. 2001;111:1533–1544.
   PubMed Web of Science ®Google Scholar
• Liu T. Adenoid cystic carcinoma of the nasopharynx: 27-year experience. Laryngoscope. 2008;11:1988–1988.
   Google Scholar
• Wen SX, Tang PZ, Xu ZG, et al. Therapeutic modalities of nasopharyngeal adenoid cystic carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2006;41:359–361.
   PubMedGoogle Scholar
• Cao C, Luo J, Xu G, et al. Management of nasopharyngeal adenoid cystic carcinoma. J Oral Maxillofac Surg. 2013;71:e203–e209.
   PubMed Web of Science ®Google Scholar
• Gentile MS, Yip D, Liebsch NJ, et al. Definitive proton beam therapy for adenoid cystic carcinoma of the nasopharynx involving the base of skull. Oral Oncol. 2017;65:38–44.
   PubMed Web of Science ®Google Scholar
• Takagi M, Demizu Y, Hashimoto N, et al. Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck. Radiother Oncol. 2014;113:364–370.
   PubMed Web of Science ®Google Scholar
• Samant S, van den Brekel Michiel W, Kies MS, et al. Concurrent chemoradiation for adenoid cystic carcinoma of the head and neck. Head Neck. 2012;34:1263–1268.
   PubMed Web of Science ®Google Scholar
• Ko JJ, Siever JE, Hao D, et al. Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre. Curr Oncol. 2016;23:26.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Stewart AK, Winchester DP, et al. The national cancer data base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683–690.
   PubMed Web of Science ®Google Scholar
• Moreno AC, Verma V, Hofstetter WL, et al. Patterns of care and treatment outcomes of elderly patients with stage I esophageal cancer: analysis of the national cancer data base. J Thorac Oncol. 2017;12:1152–1160.
   PubMed Web of Science ®Google Scholar
• Stahl JM, Corso CD, Verma V, et al. Trends in stereotactic body radiation therapy for stage I small cell lung cancer. Lung Cancer. 2017;103:11–16.
   PubMed Web of Science ®Google Scholar
• Verma V, McMillan MT, Grover S, et al. Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (≥5 centimeter) non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;97:146–154.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Stewart AK, et al. Comparison of commission on cancer–approved and–nonapproved hospitals in the united states: implications for studies that use the national cancer data base. J Clin Oncol. 2009;27:4177–4181.
   PubMed Web of Science ®Google Scholar
• Boffa DJ, Rosen JE, Mallin K, et al. Using the national cancer database for outcomes research: a review. JAMA Oncol. 2017;3:1722–1728.
   PubMed Web of Science ®Google Scholar
• Bott MJ, Patel AP, Verma V, et al. Patterns of care in hilar node-positive (N1) non-small cell lung cancer: a missed treatment opportunity? J Thorac Cardiovasc Surg. 2016;151:1549–1558.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma. J Neurooncol. 2017;133:369–375.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. National practice patterns and outcomes for T4b urothelial cancer of the bladder. Clin Genitourin Cancer. 2017 [cited 2017 Sep 6]. DOI:10.1016/j.clgc.2017.08.013
   PubMed Web of Science ®Google Scholar
• McMillan MT, Ojerholm E, Verma V, et al. Radiation treatment time and overall survival in locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;98:1142–1152.
   PubMed Web of Science ®Google Scholar
• Verma V, Ryckman JM, Simoe CB 2nd, et al. Patterns of care and outcomes with the addition of chemotherapy to radiation therapy for stage I nasopharyngeal cancer. Acta Oncol. 2017 [cited 2017 Jul 19]; [5 p.]. DOI:10.1080/0284186X.2017.1351039
   Web of Science ®Google Scholar
• Verma V, Ahern CA, Berlind CG, et al. National Cancer Database Report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma. J Thorac Oncol. 2017;12:1704–1714.
   PubMed Web of Science ®Google Scholar
• Haque W, Vema V, Fakhreddine M, et al. Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: analysis of the National Cancer Data Base. Gynecol Oncol. 2017;144:28–33.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma. J Neurooncol. 2017;135:173–181.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Radical cystectomy versus chemoradiation for muscle-invasive bladder cancer: impact of treatment facility and sociodemographics. Anticancer Res. 2017;37:5603–5608.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Radiation dose in neoadjuvant chemoradiation therapy for esophageal cancer: patterns of care and outcomes from the National Cancer Data Base. J Gastrointest Oncol. 2017. DOI:10.21037/jgo.2017.09.12
   Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Addition of chemotherapy to hypofractionated radiotherapy for glioblastoma: practice patterns, outcomes, and predictors of survival. J Neurooncol. 2017 [cited 2017 Oct 31]. DOI:10.1007/s11060-017-2654-y
   Web of Science ®Google Scholar
• Verma V, Allen PK, Simone CB 2nd, et al. Association of treatment at high-volume facilities with survival in Patients Receiving Chemoradiotherapy for Nasopharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2017 [cited 2017 Nov 2]. DOI:10.1001/jamaoto.2017.1874
   PubMed Web of Science ®Google Scholar
• Verma V, Allen PK, Simone CB 2nd, et al. Addition of definitive radiotherapy to chemotherapy in patients with newly diagnosed metastatic nasopharyngeal cancer. J Natl Compr Canc Netw. 2017;15:1383–1391.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Chemotherapy versus chemoradiation for node-positive bladder cancer: practice patterns and outcomes from the National Cancer Data Base. Bladder Cancer. 2017;3:283–291.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Bernicker E, et al. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base. Acta Oncol. 2017 [cited 2017 Nov 30]; [8 p.]. DOI:10.1080/0284186X.2017.1409435
   Web of Science ®Google Scholar
• Haque W, Lewis GD, Verma V, et al. The role of adjuvant chemotherapy in locally advanced bladder cancer. Acta Oncol. 2017 [cited 2017 Dec 11]; [7 p.]. DOI:10.1080/0284186X.2017.1415461
   Web of Science ®Google Scholar
• Verma V, Sukar SM, Brooks ED, et al. Chemoradiotherapy versus chemotherapy alone for unresected nonmetastatic gallbladder cancer: National Practice Patterns and Outcomes. J Natl Compr Canc Netw. 2018;16:59–65.
   PubMed Web of Science ®Google Scholar
• Verma V, Simone CB 2nd, Lin C. Human papillomavirus and nasopharyngeal cancer. Head Neck. 2018. DOI:10.1002/hed.24978
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Naik N, et al. Metaplastic breast cancer: practice patterns, outcomes, and the role of radiotherapy. Ann Surg Oncol. 2018. DOI:10.1245/s10434-017-6316-2
   PubMed Web of Science ®Google Scholar
• Mohanty S, Bilimoria KY. Comparing national cancer registries: the national cancer data base (NCDB) and the surveillance, epidemiology, and end results (SEER) program. J Surg Oncol. 2014;109:629–630.
   PubMed Web of Science ®Google Scholar
• Lerro CC, Robbins AS, Phillips JL, et al. Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann Surg Oncol. 2013;20:1759–1765.
   PubMed Web of Science ®Google Scholar
• King AD, Ahuja AT, Leung S, et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck. 2000;22:275–281.
   PubMed Web of Science ®Google Scholar
• Ng S, Chang JT, Chan S, et al. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004;31:1073–1080.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ma J, Lu TX, et al. Regulation for distribution of metastatic cervical lymph nodes of 512 cases of nasopharyngeal carcinoma. Ai Zheng. 2004;23:1523–1527.
   PubMedGoogle Scholar
• Laurie SA, Ho AL, Fury MG, et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol. 2011;12:815–824.
   PubMed Web of Science ®Google Scholar